Organon announced significant leadership changes Oct. 27 as part of its response to an internal investigation into improper sales practices related to its Nexplanon product. Ali The company’s board of ...

Thanks to the corner of TikTok dubbed “BookTok,” fantasy and science fiction books have recently seen a boost in popularity — and pharma marketers are taking notice. Fantasy and science fiction book ...

With massive social media hype around its intricate world-building and steamy love scenes, perhaps no literary genre has made quite as big of a splash in recent years as the fantasy-romance segment, ...

Carrie Cox announced her transition to Executive Chair, taking a more active management role following the Board’s investigation into improper U.S. sales practices for Nexplanon. Cox stated, "The ...

CEO Kevin Ali stated that Q1 2025 results met expectations, with Nexplanon achieving double-digit growth and projected to exceed $1 billion in revenue for the year. He highlighted the success of the ...

Oct 27 (Reuters) - Organon (OGN.N), opens new tab said on Monday CEO Kevin Ali will resign from his role, after an internal investigation into sales of its Nexplanon contraceptive implant to ...

Organon (NYSE:OGN) shares fell 18% on Monday after the company announced that CEO Kevin Ali has resigned following the results of an internal investigation into improper wholesaler sales practices ...